141 related articles for article (PubMed ID: 4597861)
1. Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease.
Sokal JE; Aungst CW; Han T
Int J Cancer; 1973 Jul; 12(1):242-9. PubMed ID: 4597861
[No Abstract] [Full Text] [Related]
2. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
3. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
4. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
Libánský J; Jezková Z
Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
[No Abstract] [Full Text] [Related]
5. The investigation of the immunological reactivity of patients with haemoblastosis.
Libánský J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
[No Abstract] [Full Text] [Related]
6. Impaired immunoresponsiveness in tumor patients.
Harris J; Copeland D
Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
[No Abstract] [Full Text] [Related]
7. Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: alterations induced by a tumour burden and by BCG administration.
Magrath IT
Int J Cancer; 1974 Jun; 13(6):839-49. PubMed ID: 4604572
[No Abstract] [Full Text] [Related]
8. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
Stramignoni A; Navone R; Meriggi E
Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
[No Abstract] [Full Text] [Related]
9. Use of BCG in the treatment of human neoplasms: a review.
Nathanson L
Semin Oncol; 1974 Dec; 1(4):337-50. PubMed ID: 4620439
[No Abstract] [Full Text] [Related]
10. [Passive transmission of the tuberculin allergy in sarcoidosis and in malignant lymphomas].
Kohout J
Wien Klin Wochenschr; 1967 Oct; 79(43):795-8. PubMed ID: 4872281
[No Abstract] [Full Text] [Related]
11. [Significance of the HL-A-antigensystem in tumor research].
Kuwert E; Bertrams J
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
[No Abstract] [Full Text] [Related]
12. Cellular immune responses and prognosis in malignant lymphomas.
Sokal JE; Aungst CW
Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
[No Abstract] [Full Text] [Related]
13. Complications of BCG vaccination in neoplastic disease.
Aungst CW; Sokal JE; Jager BV
Ann Intern Med; 1975 May; 82(5):666-9. PubMed ID: 1056158
[TBL] [Abstract][Full Text] [Related]
14. [Value and action of cytostatics in malignant lymphatic system diseases].
FLEISCHHACKER H; STACHER A
Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
[No Abstract] [Full Text] [Related]
15. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
16. Delay in progression of malignant lymphoma after BCG vaccination.
Sokal JE; Aungst CW; Snyderman M
N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
[No Abstract] [Full Text] [Related]
17. Immunotherapy of leukemia and lymphoma.
Murphy S; Hersh E
Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
[No Abstract] [Full Text] [Related]
18. [Lymphomas and immunity].
Kouvalainen K
Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
[No Abstract] [Full Text] [Related]
19. An overview of cancer immunology.
Ritts RE; Neel HB
Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
[No Abstract] [Full Text] [Related]
20. BCG and cancer.
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
